Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Abstract excerpt

Research in two fronts has enabled the development of therapies that provide significant benefit to cancer patients. One area stems from a detailed knowledge of mutations that activate or inactivate signaling pathways that drive cancer development. This work triggered the development of targeted therapies that lead to clinical responses in the majority of patients bearing the targeted mutation, although responses...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Delivery Systems
• Share to Immunotherapy
• Share to Mutation